TRACK RECORD

Talent Biotechs

Using Cannabidiol in an innovative strategy for graft-versus-host disease (GVHD) prevention and treatment Sold on February 2017.

Stero Biotechs

Using CBD for steroid-sparing therapy
Stero has multiple ongoing phase 2a clinical trials

CannaLean Biotechs

Addressing an unmet need by using a novel formulation of CBD to significantly reduce lipid blood levels.
2 Phase 2a clinical trials are planned in the near future